BofA lowered the firm’s price target on CME Group (CME) to $204 from $212 and keeps an Underperform rating on the shares. Volatility receded significantly in Q3, which dampened exchange volumes across most asset classes, says the analyst, who is cutting near-term EPS estimates for most of the firm’s exchange coverage.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CME:
- CME Group reports September ADV of 26.1M contracts
- Crypto Currents: Bitcoin surges as cryptocurrency market cap tops $4T
- CME Group price target raised to $312 from $303 at Morgan Stanley
- Freeport-McMoRan, Biogen, Intel, Uranium Energy, CME Trending by Analysts
- Early notable gainers among liquid option names on September 25th